Negative Pressure Wound Therapy Market (By Product Type: Conventional NPWT Devices, Single-use NPWT Devices, NPWT Accessories; By Wound Type: Chronic Wounds, Pressure Ulcer, Acute Wounds; By End-use Type: Hospital, Specialty Clinics, Home Healthcare, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Negative Pressure Wound Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Negative Pressure Wound Therapy Market Revenue and Volume, by Product Type, 2024-2033
8.1.1 Conventional NPWT Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Single-use NPWT Devices
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. NPWT Accessories
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1. Negative Pressure Wound Therapy Market Revenue and Volume, by Wound Type, 2024-2033
9.1.1. Chronic Wounds
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Acute Wounds
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1. Negative Pressure Wound Therapy Market Revenue and Volume, by End-use Type, 2024-2033
10.1.1. Hospital
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Specialty Clinics
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Home Healthcare
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)
12.1. Acelity
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Conva Tec Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Cardinal Health
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cork Medical
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. DeRoyal Industries, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Genadyne Biotechnologies Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Invacare Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. 3M
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Molnlycke Health Care
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Paul Hartmann AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample